These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18448450)

  • 1. A rationale for starting breast cancer screening under age 50.
    van Schoor G; Broeders MJ; Paap E; Otten JD; den Heeten GJ; Verbeek AL
    Ann Oncol; 2008 Jun; 19(6):1208-9. PubMed ID: 18448450
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality reduction by breast-cancer screening.
    Bonneux L
    Lancet; 2003 Jul; 362(9379):245. PubMed ID: 12885491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Decrease in breast cancer mortality due to mass screening with mammography; results of the Nijmegen mass screening project 1975-1981].
    Verbeek AL; Hendriks JH; Holland R; Mravunac M; Sturmans F; Day NE
    Ned Tijdschr Geneeskd; 1985 Mar; 129(10):451-4. PubMed ID: 3982520
    [No Abstract]   [Full Text] [Related]  

  • 4. No major impact of mammography screening on the age specific incidence rates of breast cancer in the Netherlands.
    Verkooijen HM; Fioretta G; van der Heiden M; Koot VC; Bouchardy C
    Int J Cancer; 2006 Dec; 119(12):2988; author reply 2989-90. PubMed ID: 17016822
    [No Abstract]   [Full Text] [Related]  

  • 5. Mortality reduction by breast-cancer screening.
    Gøtzsche PC
    Lancet; 2003 Jul; 362(9379):246. PubMed ID: 12885494
    [No Abstract]   [Full Text] [Related]  

  • 6. Age and interval for screening mammography: whom do you believe?
    Venta LA; Goodhartz LA
    Semin Surg Oncol; 1996; 12(5):281-9. PubMed ID: 8873315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Voogd AC; Jansen FH; Hooijen MJ; Louwman MW
    Radiology; 2011 Aug; 260(2):357-63. PubMed ID: 21474705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 10. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic screening is dramatically changing age-incidence data for breast cancer.
    Hemminki K; Rawal R; Bermejo JL
    J Clin Oncol; 2004 Nov; 22(22):4652-3. PubMed ID: 15542818
    [No Abstract]   [Full Text] [Related]  

  • 12. The predictive value of positive test results in screening for breast cancer by mammography in the Nijmegen programme.
    Peeters PH; Verbeek AL; Hendriks JH; Holland R; Mravunac M
    Br J Cancer; 1987 Nov; 56(5):667-71. PubMed ID: 3426934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated mammographic screening reduces breast cancer mortality along the continuum of age.
    Broeders MJ; Verbeek AL; Straatman H; Peer PG; Jong PC; Beex LV; Hendriks JH; Holland R
    J Med Screen; 2002; 9(4):163-7. PubMed ID: 12518006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Mammography in Women 40-49 Years Old: Current Evidence.
    Ray KM; Joe BN; Freimanis RI; Sickles EA; Hendrick RE
    AJR Am J Roentgenol; 2018 Feb; 210(2):264-270. PubMed ID: 29064760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for breast cancer after the age of 70: effect on breast cancer mortality].
    van Dijck JA; Verbeek AL; Hendriks JH; Holland R
    Ned Tijdschr Geneeskd; 1995 Mar; 139(9):428-33. PubMed ID: 7891764
    [No Abstract]   [Full Text] [Related]  

  • 16. Doubts on the future cost-effectiveness and desirability of population-based breast screening in The Netherlands.
    Coebergh JW
    Acta Clin Belg Suppl; 1993; 15():6-11. PubMed ID: 8517096
    [No Abstract]   [Full Text] [Related]  

  • 17. Mammography: reviewing the evidence. Epidemiology aspect.
    Miller AB
    Can Fam Physician; 1993 Jan; 39():85-90. PubMed ID: 8435565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of breast cancer with mammography in the first screening round in relation to expected incidence in different age groups.
    Jonsson H; Larsson LG; Lenner P
    Acta Oncol; 2003; 42(1):22-9. PubMed ID: 12665327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme.
    Peeters PH; Verbeek AL; Straatman H; Holland R; Hendriks JH; Mravunac M; Rothengatter C; Van Dijk-Milatz A; Werre JM
    Int J Epidemiol; 1989 Jun; 18(2):295-9. PubMed ID: 2788627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mammography for mass screening].
    van Bekkum DW
    Ned Tijdschr Geneeskd; 1978 Apr; 122(17):600-4. PubMed ID: 652071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.